Fiscal impact reports (FIRs) are prepared by the Legislative Finance Committee (LFC) for standing finance
committees of the NM Legislature. The LFC does not assume responsibility for the accuracy of these reports
if they are used for other purposes.
Current FIRs (in HTML & Adobe PDF formats) are a vailable on the NM Legislative Website (legis.state.nm.us).
Adobe PDF versions include all attachments, whereas HTML versions may not. Previously issued FIRs and
attachments may be obtained from the LFC in Suite 101 of the State Capitol Building North.
F I S C A L I M P A C T R E P O R T
SPONSOR SJC
ORIGINAL DATE
LAST UPDATED
02/20/07
HB
SHORT TITLE Clarifying Oriental Medicine Practice
SB 353/SJCS
ANALYST Hanika Ortiz
REVENUE (dollars in thousands)
Estimated Revenue
Recurring
or Non-Rec
Fund
Affected
FY07
FY08
FY09
($0.75)
Recurring
Board of
Acupuncture
and Oriental
Medicine
(Parenthesis ( ) Indicate Revenue Decreases)
SOURCES OF INFORMATION
LFC Files
SUMMARY
Synopsis of Bill
The Senate Judiciary Committee Substitute amends the Acupuncture and Oriental Medicine
Practice Act in three areas:
Amends 61-14A-3 NMSA 1978 and expands the definition of “techniques of oriental medicine"
to add combining and dispensing of a variety of substances and devices as described in the bill
and defined in the New Mexico Drug, Device and Cosmetics Act; and, nonprescription drugs as
they are defined in the Pharmacy Act.
Amends Section 61-14A-4.1 NMSA 1978 and deletes the annual renewal requirement and fee
for doctors of oriental medicine who register to supervise certified auricular detoxification
specialists.
Amends Section 61-14A-8.1 NMSA 1978 to allow the board to issue expanded practice and
prescriptive authority certifications for certain substances as defined in the New Mexico Drug,
Device and Cosmetic Act, the Controlled Substances Act or the Pharmacy Act; and, issue more
specialized certifications to distinguish among those licensees who specialize in basic injection
therapy, injection therapy, intravenous therapy and bioidentical hormone therapy subject to rules